SCHEMBL3858025

SCHEMBL3858025

Fc1ccc(-c2n[nH]cc2-c2ccc3nccc(-c4ccccn4)c3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 6/20 0.43
MAPK14 Q16539 5/20 0.40
PIK3CA P42336 2/20 0.39
ALOX5 P09917 2/20 0.38
ACVR1 Q04771 2/20 0.38
PRKCI P41743 1/20 0.38
METAP2 P50579 1/20 0.38
METAP1 P53582 1/20 0.38
CBFB Q13951 1/20 0.38
SQOR Q9Y6N5 2/20 0.37
DYRK1B Q9Y463 1/20 0.37
TGFBR2 P37173 1/20 0.36
ABL2 P42684 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CSNK1D P48730 1/20 0.36
MAP3K20 Q9NYL2 1/20 0.36
CLK2 P49760 1/20 0.36
CLK3 P49761 1/20 0.36
DYRK1A Q13627 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850901 0.85 DYRK1A (0.41) TGFBR1MAPK14PIK3CAMETAP2METAP1
Hydrochloric Acid SCHEMBL3853873 0.84 DYRK1A (0.40) TGFBR1MAPK14PIK3CAMETAP2METAP1
SCHEMBL7856946 0.83 TGFBR1 (0.51) TGFBR1MAPK14METAP1SQOR
Hydrochloric Acid SCHEMBL3846888 0.81 ACVR1 (0.41) TGFBR1MAPK14PIK3CAACVR1PRKCI
SCHEMBL5139747 0.81 TGFBR1 (0.40) TGFBR1MAPK14PIK3CAACVR1DYRK1B
SCHEMBL3859370 0.80 ACVR1 (0.44) MAPK14PIK3CAALOX5ACVR1
Gw680975X SCHEMBL373303 0.80 TGFBR1 (0.59) TGFBR1MAPK14SQOR
SCHEMBL5490810 0.79 TGFBR1 (0.54) TGFBR1MAPK14METAP1SQOR
SCHEMBL3852041 0.78 TDO2 (0.49) MAPK14PIK3CADYRK1A
SCHEMBL14519488 0.78 MAPK14 (0.55) TGFBR1MAPK14ALOX5ACVR1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed